APG
APi Group Corporation
Latest News for APG
In a report released on April 2, Julian Harrison from BTIG reiterated a Buy rating on Apogee Therapeutics, with a price target of $137.00. The comp......
In a report released on April 2, Julian Harrison from BTIG reiterated a Buy rating on Apogee Therapeutics, with a price target of $137.00. The comp......
CICC analyst maintained a Buy rating on Ascentage Pharma Group International yesterday and set a price target of HK$71.20. Ascentage Pharma Group I......
Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Apogee Therapeutics yesterday and set a price target of $160.00. The company’s share......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ascentage Pharma Group International Unsponsored ADR (AAPG), Rock......
BTIG analyst Jeet Mukherjee reiterated a Buy rating on Ascentage Pharma Group International Unsponsored ADR yesterday and set a price target of $48......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE) and Theriva Biologics (......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN), Apogee Therapeutics (APGE) and Gilead Sciences (GIL......
Traders seeking the top stock market stories for Monday will find them in the TipRanks daily wrap-up. ...
Apogee Therapeutics stock gained on Monday alongside strong results from the company’s latest clinical trial. ...
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 19 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APG | $43.93 | +4.7% | 1.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |